PERCEPTIVE ADVISORS LLC 13D and 13G filings for Contineum Therapeutics, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 1,441,249 5.600% | -125,420 (-8.01%) | Filing |
| 2024-04-15 4:20 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | PERCEPTIVE ADVISORS LLC | 1,566,669 8.500% | 1,566,669 (New Position) | Filing |